CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

OBJECTIVE: The diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) must be improved before widespread clinical use. This study aimed to determine whether CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios are better diagnostic biomarkers of AD during both predementia and de...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Zetterberg, Henrik, Mattsson, Niklas, Palmqvist, Sebastian, Vanderstichele, Hugo, Lindberg, Olof, van Westen, Danielle, Stomrud, Erik, Minthon, Lennart, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774260/
https://www.ncbi.nlm.nih.gov/pubmed/27042676
http://dx.doi.org/10.1002/acn3.274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774260/
https://www.ncbi.nlm.nih.gov/pubmed/27042676
http://dx.doi.org/10.1002/acn3.274

Ejemplares similares